Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Baum, Lara
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
Hans-Wolfgang-Klingelhöfer-Gasse 2-9
85354 Freising (Germany)
ID: 3227-921774-2 (ECI)
Report
Date: 21-OCT-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
KfH-Nierenzentrum am Klinikum Freising
Alois-Steinecker-Straße 16
85354 Freising (Germany)
Specimen
Collected: 21-OCT-2018

Chemistry

Test 21-OCT-2018 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 71.2 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.0 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 105.5 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.2 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 256.7 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 102.4 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 188.2 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 48.1 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating impaired glucose control or possible diabetes, and significantly increased total cholesterol and LDL cholesterol, suggesting high cardiovascular risk. Other parameters, including kidney function, electrolytes, and triglycerides, are within normal limits. Recommend further evaluation and management of glycemic control and lipid profile to reduce long-term complications.